相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation
J. C. Marsh et al.
BONE MARROW TRANSPLANTATION (2014)
Immune reconstitution in patients with Fanconi anemia after allogeneic bone marrow transplantation
Miriam Perlingeiro Beltrame et al.
CYTOTHERAPY (2014)
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience
Regis Peffault de Latour et al.
BLOOD (2013)
Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia
S. Gandhi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
The Saudi Experience in Fludarabine-Based Conditioning Regimens in Patients with Fanconi Anemia Undergoing Stem Cell Transplantation: Excellent Outcome in Recipients of Matched Related Stem Cells but Not in Recipients of Unrelated Cord Blood Stem Cells
Mouhab Ayas et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Diagnosis and management of acute graft-versus-host disease
Fiona L. Dignan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Diagnosis and management of chronic graft-versus-host disease
Fiona L. Dignan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Bone Marrow Transplantation for Fanconi Anemia Using Fludarabine-Based Conditioning
Polina Stepensky et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Robert J. Soiffer et al.
BLOOD (2011)
Alemtuzumab in allogeneic hematopoetic stem cell transplantation
Xavier Poire et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Alemtuzumab for the prevention and treatment of graft-versus-host disease
Junya Kanda et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution
Ronjon Chakraverty et al.
BLOOD (2010)
Haematopoeitic cell transplantation for Fanconi anaemia - when and how?
Margaret L. MacMillan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
HLA-Matched sibling hematopoietic stem cell transplantation for Fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens
Ricardo Pasquini et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 year's experience
M. Ayas et al.
BONE MARROW TRANSPLANTATION (2008)
Immune reconstitution following hematopoietic stem-cell transplantation
Michelle Geddes et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia
John E. Wagner et al.
BLOOD (2007)
Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8(+)CD3(+) count reconstitution is associated with survival
U. Koehl et al.
BONE MARROW TRANSPLANTATION (2007)
Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors
M. Bitan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation
PL Tan et al.
PEDIATRIC BLOOD & CANCER (2006)
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity
A Shimoni et al.
LEUKEMIA (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment
DP Blaise et al.
CANCER (2005)
Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants
PS Rosenberg et al.
BLOOD (2005)
Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland
LR Bisset et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Radiation response in vitro of fibroblasts from a fanconi anemia patient with marked clinical radiosensitivity
C Djuzenova et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2004)
Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome
P Guardiola et al.
BLOOD (2004)
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution
S Chakrabarti et al.
BLOOD (2002)
Bone marrow transplantation from matched siblings in patients with Fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin
M Ayas et al.
BONE MARROW TRANSPLANTATION (2001)
Evolving strategies to address adverse transplant outcomes associated with T cell depletion
WR Drobyski
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2000)
分享论文
